Abstract: A label printing and attaching system includes a label printing device and a label attaching device. The label printing device has an ink tape supply mechanism for supplying an ink tape with a label pattern. A label tape supply mechanism of the label printing device is adapted to supply a label tape that includes a carrier tape and blank label paper adhered to the carrier tape. The label printing device further includes a heat transfer machine adapted to heat transfer the label pattern on the ink tape onto the blank label paper of the label tape to obtain a desired label. The label attaching device has a label picker adapted to pick up the label with the printed label pattern from the label tape, and a moving device adapted to move the label picker to place the picked label with the printed label pattern onto a product.

Abstract: Provided is an Interleukin-1 Receptor Antagonist (IL-1RN) protein or a variant or analogue thereof, and a fusion protein comprising the following three-parts: the Interleukin-1 Receptor Antagonist protein or a variant or analogue thereof, a domain for half-life extension and an optional tumor necrosis factor receptor 2, and the preparation method and use thereof. The above-mentioned protein mutant and fusion protein have the effects of extended half-life, improved affinity with interleukin-1 receptor and superior biological activity, and find use in the field of treatment and prevention of inflammatory-associated diseases.

Abstract: Provided is a fusion polypeptide as an antagonist for IL4 and IL13. Also provided is a pharmaceutical composition comprising the fusion polypeptide and a pharmaceutically acceptable excipient.

Abstract: In some aspects, the present disclosure provides antibodies with high target affinities, as well as compositions comprising the same, and methods of using the same. In some embodiments, antibodies against an IL6 receptor are provided.

Abstract: Provided are a hydration method for a lyophilized cyclophosphamide composition and a composition and preparation prepared thereby. The hydration method comprises: (a) providing an aqueous solution comprising cyclophosphamide and an optional pharmaceutically acceptable excipient; (b) freeze-drying the solution to obtain a lyophilized composition; and (c) hydrating the lyophilized composition by using liquid water to obtain the product.

Abstract: Provided are novel antibodies with high target affinities against an IL6 receptor. Further provided are compositions containing such antibodies and methods of using the same.

Abstract: In some aspects, the present disclosure provides polypeptides with high binding affinities for ligands, as well as compositions comprising the same, and methods of using the same. In some embodiments, polypeptides having high binding affinity for CD80, CD86, or both are provided.

Abstract: Provided is a process for hydrating Cyclophosphamide freeze-dried compositions and products obtained therefrom.

Abstract: Provided are novel antibodies with high target affinities against an IL6 receptor. Further provided are compositions containing such antibodies and methods of using the same.